News

April 17, 2017April 17, 2017

MURDOCK Study Aims to Determine Real-World Impact of COPD

COPD, News

The Duke Clinical Research Institute (DCRI), the MURDOCK Study and Boehringer Ingelheim are collaborating on a new observational study to understand the real-world impact of chronic obstructive pulmonary disease (COPD). ... Read more

April 13, 2017April 13, 2017

NuMedii and Three Lakes Partners Collaborate to Discover New Therapies for IPF

Idiopathic Pulmonary Fibrosis, News

NuMedii and Three Lakes Partners are collaborating to discover and advance new therapies for idiopathic pulmonary fibrosis (IPF). Under the agreement, the companies will use NuMedii’s predictive big data intelligence technology, ... Read more

April 12, 2017April 13, 2017

Researchers Develop New Probe to Follow PF Progression, Treatment

Idiopathic Pulmonary Fibrosis, News

Researchers developed a new probe to use in positron emission tomography (PET) imaging that may help diagnose and monitor pulmonary fibrosis, according to a study. The probe, called 68Ga-CBP8, binds ... Read more

April 11, 2017April 11, 2017

Researchers Review Performance of Genentech’s Esbriet in Treating Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis, News

Genentech’s Esbriet (pirfenidone), approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat idiopathic pulmonary fibrosis (IPF), prolongs survival in patients and is generally safe, concludes a review, “Role ... Read more

April 10, 2017April 10, 2017

Positive Trial Data Evaluating Anabasum to Treat CF Announced by Corbus

Cystic Fibrosis, News

Topline data from a Phase 2 clinical trial evaluating multiple doses of anabasum compared to placebo shows promising results in the treatment of pulmonary exacerbations in patients with cystic fibrosis (CF), ... Read more

April 7, 2017April 7, 2017

Lung Institute Wants to Raise Awareness of COPD-Depression Link on World Health Day

COPD, News

The Lung Institute is trying to raise awareness of the link between chronic obstructive pulmonary disease (COPD) and depression in honor of World Health Day, whose focus this year is depression. ... Read more

April 5, 2017April 5, 2017

Yankees’ Bernie Williams Raising Pulmonary Fibrosis Awareness to Honor His Late Father

Idiopathic Pulmonary Fibrosis, News

Retired New York Yankee great Bernie Williams is collaborating with Boehringer Ingelheim to raise awareness of idiopathic pulmonary fibrosis (IPF) in honor of his father, Bernabé, who died of the ... Read more

April 4, 2017April 4, 2017

Tezacaftor-Kalydeco Combo Is Promising CF Treatment, Phase 3 Trials Show

Cystic Fibrosis, News

A combination of tezacaftor and ivacaftor significantly improved lung function in cystic fibrosis (CF) patients 12 years and older who had a F508del mutation, according to two Phase 3 clinical ... Read more

April 3, 2017April 3, 2017

Stem Cells Reduce Lung Inflammation and Damage in Mouse Model of COPD and Cystic Fibrosis

COPD, Cystic Fibrosis, News

A ground-breaking experiment using mesenchymal stem cells (MSCs) injected into mice models of chronic obstructive pulmonary disease (COPD) and cystic fibrosis showed that MSC therapy might be a promising approach to ... Read more

March 31, 2017March 31, 2017

Chantix is Effective, Safe Therapy to Stop Smoking, Researchers Opine

Lung Cancer, News

Chantix (varenicline) is an effective and safe therapy to quit smoking, according to researchers from the Charles E. Schmidt College of Medicine at Florida Atlantic University. The therapy ultimately could have prevented heart attacks ... Read more